Table 2.
Levothyroxine tablet product | Reference listed druga | Therapeutic equivalence codeb | Inactive ingredientsc |
---|---|---|---|
Brand name | |||
Unithroid | Yes | AB1, AB2, AB3 | Acacia, colloidal silicon dioxide, corn starch, lactose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate |
Synthroid | Yes | AB1, AB2 | Acacia, confectioner’s sugar (contains corn starch), lactose monohydrate, magnesium stearate, povidone, talc |
Levoxyl | Yes | AB1, AB3 | Calcium sulfate dehydrate, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, sodium bicarbonate |
Levo-T | No | AB1, AB2, AB3 | Magnesium stearate, microcrystalline cellulose, colloidal silicone dioxide, sodium starch glycolate |
Euthyrox | No | AB2 | Citric acid anhydrous, corn starch, gelatin, magnesium stearate, mannitol, sodium croscarmellose |
Generic | |||
Levothyroxine sodium (Mylan) | No | AB1, AB2, AB3, AB4 | Butylated hydroxyanisole, colloidal silicon dioxide, crospovidone, ethyl alcohol, magnesium stearate, mannitol, microcrystalline cellulose, povidone, sodium lauryl sulfate, sucrose |
aA drug identified by the FDA as a product on which an applicant relies in seeking approval of an abbreviated new drug application for a generic product
bIf bioequivalence to a reference listed drug product is demonstrated, the product will be given the same code as the reference listed drug it was compared against: AB1 vs. Unithroid, AB2 vs. Synthroid, AB3 vs. Levoxyl; AB4 vs. Levothroid/Thyro-Tabs (now discontinued). One common code indicates therapeutic equivalence between products
cAll formulations except Euthyrox also contain colorants that differ according to tablet dose